Inhibition of B cell receptor-mediated apoptosis by IFN
- PMID: 10352242
Inhibition of B cell receptor-mediated apoptosis by IFN
Abstract
IFNs are a family of cytokines that are involved in the regulation of immune and inflammatory responses. Clinical use of IFN-alpha/beta encompasses treatment for a variety of diseases; however, prolonged exposure to IFN-alpha/beta results in elevated levels of autoreactive Abs. In this study, we investigated the potential of IFNs to modulate apoptotic signals in B cells. We demonstrate that IFN-alpha or IFN-beta inhibit Ag receptor-mediated apoptosis in a dose-dependent manner. Inhibition of phosphatidylinositol 3' (PI3)-kinase did not abolish the effect of IFN, indicating that the antiapoptotic mechanism is PI3-kinase- and protein kinase B/Akt-independent. Instead, IFN-alpha and IFN-beta, but not IFN-gamma, significantly increase the levels of the survival protein Bcl-2, and to a lesser extent, Bcl-xL expression. Thus, IFN-alpha/beta-mediated inhibition of B cell Ag receptor-triggered apoptosis may offer a model for the process that leads to the escape of self-reactive B cells from negative selection and consequently results in autoantibody production.
Similar articles
-
Temporal ordering of caspase activation and substrate cleavage during antigen receptor-triggered apoptosis in Ramos-Burkitt lymphoma B cells.Int J Oncol. 2003 Aug;23(2):257-68. Int J Oncol. 2003. PMID: 12851674
-
CD40 and adenosine A2 receptor agonist-cyclic adenosine monophosphate rescue B-cell antigen receptor-induced apoptosis through independent pathways and converge to prevent caspase activation.J Allergy Clin Immunol. 2000 Mar;105(3):522-31. doi: 10.1067/mai.2000.104251. J Allergy Clin Immunol. 2000. PMID: 10719303
-
Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways.Cancer Res. 2000 Dec 15;60(24):7170-6. Cancer Res. 2000. PMID: 11156427
-
Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway.Exp Cell Res. 2006 May 1;312(8):1229-39. doi: 10.1016/j.yexcr.2005.12.011. Epub 2006 Jan 19. Exp Cell Res. 2006. PMID: 16427044
-
Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.Oncogene. 2004 Nov 11;23(53):8619-28. doi: 10.1038/sj.onc.1207905. Oncogene. 2004. PMID: 15361852
Cited by
-
Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood.Mol Neurobiol. 2013 Dec;48(3):737-56. doi: 10.1007/s12035-013-8463-1. Epub 2013 May 1. Mol Neurobiol. 2013. PMID: 23636981
-
Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.J Exp Med. 2000 May 15;191(10):1777-88. doi: 10.1084/jem.191.10.1777. J Exp Med. 2000. PMID: 10811870 Free PMC article.
-
Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas.Br J Cancer. 2004 Jul 5;91(1):164-70. doi: 10.1038/sj.bjc.6601895. Br J Cancer. 2004. PMID: 15188008 Free PMC article.
-
Bcl-2 expression in metastatic malignant melanoma. Importance for the therapeutic efficacy of biochemotherapy.Cancer Immunol Immunother. 2003 Apr;52(4):249-54. doi: 10.1007/s00262-003-0373-z. Epub 2003 Mar 4. Cancer Immunol Immunother. 2003. PMID: 12669250 Free PMC article. Clinical Trial.
-
Adhesion to fibronectin via alpha4 integrin (CD49d) protects B cells from apoptosis induced by serum deprivation but not via IgM or Fas/Apo-1 receptors.Clin Exp Immunol. 2002 Mar;127(3):455-62. doi: 10.1046/j.1365-2249.2002.01787.x. Clin Exp Immunol. 2002. PMID: 11966761 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials